235 related articles for article (PubMed ID: 33131149)
1. Relationship between sodium channel function and clinical phenotype in SCN5A variants associated with Brugada syndrome.
Pearman CM; Denham NC; Mills RW; Ding WY; Modi SS; Hall MCS; Todd DM; Mahida S
Hum Mutat; 2020 Dec; 41(12):2195-2204. PubMed ID: 33131149
[TBL] [Abstract][Full Text] [Related]
2. Brugada syndrome: clinical presentation and genotype-correlation with magnetic resonance imaging parameters.
Rudic B; Schimpf R; Veltmann C; Doesch C; Tülümen E; Schoenberg SO; Borggrefe M; Papavassiliu T
Europace; 2016 Sep; 18(9):1411-9. PubMed ID: 26511399
[TBL] [Abstract][Full Text] [Related]
3. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
[TBL] [Abstract][Full Text] [Related]
4. Distinct Features of Probands With Early Repolarization and Brugada Syndromes Carrying SCN5A Pathogenic Variants.
Zhang ZH; Barajas-Martínez H; Xia H; Li B; Capra JA; Clatot J; Chen GX; Chen X; Yang B; Jiang H; Tse G; Aizawa Y; Gollob MH; Scheinman M; Antzelevitch C; Hu D
J Am Coll Cardiol; 2021 Oct; 78(16):1603-1617. PubMed ID: 34649698
[TBL] [Abstract][Full Text] [Related]
5. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype relationship and risk stratification in loss-of-function SCN5A mutation carriers.
Robyns T; Nuyens D; Vandenberk B; Kuiperi C; Corveleyn A; Breckpot J; Garweg C; Ector J; Willems R
Ann Noninvasive Electrocardiol; 2018 Sep; 23(5):e12548. PubMed ID: 29709101
[TBL] [Abstract][Full Text] [Related]
7. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.
Veltmann C; Barajas-Martinez H; Wolpert C; Borggrefe M; Schimpf R; Pfeiffer R; Cáceres G; Burashnikov E; Antzelevitch C; Hu D
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381756
[TBL] [Abstract][Full Text] [Related]
8. De Novo Mutation in the SCN5A Gene Associated with Brugada Syndrome.
Wang L; Meng X; Yuchi Z; Zhao Z; Xu D; Fedida D; Wang Z; Huang C
Cell Physiol Biochem; 2015; 36(6):2250-62. PubMed ID: 26279430
[TBL] [Abstract][Full Text] [Related]
9. A mutation causing Brugada syndrome identifies a mechanism for altered autonomic and oxidant regulation of cardiac sodium currents.
Aiba T; Farinelli F; Kostecki G; Hesketh GG; Edwards D; Biswas S; Tung L; Tomaselli GF
Circ Cardiovasc Genet; 2014 Jun; 7(3):249-56. PubMed ID: 24795344
[TBL] [Abstract][Full Text] [Related]
10. A Brugada syndrome proband with compound heterozygote SCN5A mutations identified from a Chinese family in Singapore.
Tan BY; Yong RY; Barajas-Martinez H; Dumaine R; Chew YX; Wasan PS; Ching CK; Ho KL; Gan LS; Morin N; Chong AP; Yap SH; Neo JL; Yap EP; Moochhala S; Chong DT; Chow W; Seow SC; Hu D; Uttamchandani M; Teo WS
Europace; 2016 Jun; 18(6):897-904. PubMed ID: 25829473
[TBL] [Abstract][Full Text] [Related]
11. GPD1L-A306del modifies sodium current in a family carrying the dysfunctional SCN5A-G1661R mutation associated with Brugada syndrome.
Semino F; Darche FF; Bruehl C; Koenen M; Skladny H; Katus HA; Frey N; Draguhn A; Schweizer PA
Pflugers Arch; 2024 Feb; 476(2):229-242. PubMed ID: 38036776
[TBL] [Abstract][Full Text] [Related]
12. Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.
Liang P; Sallam K; Wu H; Li Y; Itzhaki I; Garg P; Zhang Y; Vermglinchan V; Lan F; Gu M; Gong T; Zhuge Y; He C; Ebert AD; Sanchez-Freire V; Churko J; Hu S; Sharma A; Lam CK; Scheinman MM; Bers DM; Wu JC
J Am Coll Cardiol; 2016 Nov; 68(19):2086-2096. PubMed ID: 27810048
[TBL] [Abstract][Full Text] [Related]
13. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.
Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N
Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555
[TBL] [Abstract][Full Text] [Related]
14.
Wijeyeratne YD; Tanck MW; Mizusawa Y; Batchvarov V; Barc J; Crotti L; Bos JM; Tester DJ; Muir A; Veltmann C; Ohno S; Page SP; Galvin J; Tadros R; Muggenthaler M; Raju H; Denjoy I; Schott JJ; Gourraud JB; Skoric-Milosavljevic D; Nannenberg EA; Redon R; Papadakis M; Kyndt F; Dagradi F; Castelletti S; Torchio M; Meitinger T; Lichtner P; Ishikawa T; Wilde AAM; Takahashi K; Sharma S; Roden DM; Borggrefe MM; McKeown PP; Shimizu W; Horie M; Makita N; Aiba T; Ackerman MJ; Schwartz PJ; Probst V; Bezzina CR; Behr ER
Circ Genom Precis Med; 2020 Dec; 13(6):e002911. PubMed ID: 33164571
[TBL] [Abstract][Full Text] [Related]
15. A novel mutation in the SCN5A gene contributes to arrhythmogenic characteristics of early repolarization syndrome.
Guo Q; Ren L; Chen X; Hou C; Chu J; Pu J; Zhang S
Int J Mol Med; 2016 Mar; 37(3):727-33. PubMed ID: 26820605
[TBL] [Abstract][Full Text] [Related]
16. Genotype-Phenotype Correlation of
Milman A; Behr ER; Gray B; Johnson DC; Andorin A; Hochstadt A; Gourraud JB; Maeda S; Takahashi Y; Jm Juang J; Kim SH; Kamakura T; Aiba T; Postema PG; Mizusawa Y; Denjoy I; Giustetto C; Conte G; Huang Z; Sarquella-Brugada G; Mazzanti A; Jespersen CH; Arbelo E; Brugada R; Calo L; Corrado D; Casado-Arroyo R; Allocca G; Takagi M; Delise P; Brugada J; Tfelt-Hansen J; Priori SG; Veltmann C; Yan GX; Brugada P; Gaita F; Leenhardt A; Wilde AAM; Kusano KF; Nam GB; Hirao K; Probst V; Belhassen B
Circ Genom Precis Med; 2021 Oct; 14(5):e003222. PubMed ID: 34461752
[TBL] [Abstract][Full Text] [Related]
17. Identification of a SCN5A founder mutation causing sudden death, Brugada syndrome, and conduction blocks in Southern Italy.
Curcio A; Malovini A; Mazzanti A; Memmi M; Gambelli P; La Rosa F; Bloise R; Indolfi C; Bellazzi R; Napolitano C
Heart Rhythm; 2021 Oct; 18(10):1698-1706. PubMed ID: 34245912
[TBL] [Abstract][Full Text] [Related]
18. Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome.
Ishikawa T; Kimoto H; Mishima H; Yamagata K; Ogata S; Aizawa Y; Hayashi K; Morita H; Nakajima T; Nakano Y; Nagase S; Murakoshi N; Kowase S; Ohkubo K; Aiba T; Morimoto S; Ohno S; Kamakura S; Nogami A; Takagi M; Karakachoff M; Dina C; Schott JJ; Yoshiura KI; Horie M; Shimizu W; Nishimura K; Kusano K; Makita N
Eur Heart J; 2021 Jul; 42(29):2854-2863. PubMed ID: 34219138
[TBL] [Abstract][Full Text] [Related]
19. Functional Analysis of SCN5A Genetic Variants Associated with Brugada Syndrome.
Mikhailova VB; Karpushev AV; Vavilova VD; Klimenko ES; Tulintseva T; Yudina YS; Vasichkina ES; Zhorov BS; Kostareva A
Cardiology; 2022; 147(1):35-46. PubMed ID: 34628415
[TBL] [Abstract][Full Text] [Related]
20. Brugada syndrome disease phenotype explained in apparently benign sodium channel mutations.
Hoshi M; Du XX; Shinlapawittayatorn K; Liu H; Chai S; Wan X; Ficker E; Deschênes I
Circ Cardiovasc Genet; 2014 Apr; 7(2):123-31. PubMed ID: 24573164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
